Chromosome 5p aberrations are early events in lung cancer: Implication of glial cell line-derived neurotrophic factor in disease progression

Oncogene

Volumn 24, Issue 30, 2005, Pages 4806-4812

  Garnis, Cathie ^a   Davies, Jonathan J ^a   Buys, Timon P H ^a   Tsao, Ming Sound ^b   MacAulay, Calum ^a   Lam, Stephan ^a   Lam, Wan L ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

5p; Array CGH; Carcinoma in situ; Copy number; GDNF; TRIO

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GDNF PROTEIN, HUMAN; NERVE GROWTH FACTOR;

ARTICLE; CARCINOMA IN SITU; CHROMOSOME 5P; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; DNA FINGERPRINTING; DNA MICROARRAY; EARLY DIAGNOSIS; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LUNG CANCER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; SQUAMOUS CELL CARCINOMA; TRIPLE FUNCTIONAL DOMAIN; CANCER STAGING; CHROMOSOME 5; CHROMOSOME DELETION; CHROMOSOME MAP; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOME; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM STAGING; NERVE GROWTH FACTORS; NUCLEIC ACID HYBRIDIZATION; PHYSICAL CHROMOSOME MAPPING;

EID: 23044433717     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208643     Document Type: Article

References (35)

1. Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E and Testa JR. (1997). Cancer Res., 57, 2116-2120.
2. Bryce LA, Morrison N, Hoare SF, Muir S and Keith WN. (2000). Neoplasia, 2, 197-201.
3. Burger MJ, Tebay MA, Keith PA, Samaratunga HM, Clements J, Lavin MF and Gardiner RA. (2002). Int. J. Cancer, 100, 228-237.
4. Chi B, deLeeuw RJ, Coe BP, MacAulay C and Lam WL. (2004). BMC Bioinform., 5, 13.
5. Coe BP, Henderson LJ, Garnis C, Tsao MS, Gazdar AF, Minna J, Lam S, MacAulay C and Lam WL. (2005). Genes Chromosomes Cancer, 42, 308-313.
6. Debant A, Serra-Pages C, Seipel K, O'Brien S, Tang M, Park SH and Streuli M. (1996). Proc. Natl. Acad. Sci. USA, 93, 5466-5471.
7. Fromont-Hankard G, Philippe-Chomette P, Delezoide AL, Nessmann C, Aigrain Y and Peuchmaur M. (2002). Arch. Pathol. Lab. Med., 126, 432-436.
8. Garnis C, Baldwin C, Zhang L, Rosin MP and Lam WL. (2003). Cancer Res., 63, 8582-8585.
9. Garnis C, Buys TP and Lam WL. (2004a). Mol. Cancer, 3, 9.
10. Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP and Lam WL. (2004b). Genes Chromosomes Cancer, 39, 93-98.
11. Harris G, Azzolina B, Baginsky W, Cimis G, Rasmusson GH, Tolman RL, Raetz CR and Ellsworth K. (1992). Proc. Natl. Acad. Sci. USA, 89, 10787-10791.
12. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ. (2003). CA Cancer J. Clin., 53, 5-26.
13. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM and Haussler D. (2002). Genome Res., 12, 996-1006.
14. Krzywinski M, Bosdet I, Smailus D, Chiu R, Mathewson C, Wye N, Barber S, Brown-John M, Chan S, Chand S, Cloutier A, Girn N, Lee D, Masson A, Mayo M, Olson T, Pandoh P, Prabhu AL, Schoenmakers E, Tsai M, Albertson D, Lam W, Choy CO, Osoegawa K, Zhao S, de Jong PJ, Schein J, Jones S and Marra MA. (2004). Nucleic Acids Res., 32, 3651-3660.
15. Lam S, MacAulay C, leRiche JC and Palcic B. (2000). Cancer, 89, 2468-2473.
16. Luk C, Tsao MS, Bayani J, Shepherd F and Squire JA. (2001). Cancer Genet. Cytogenet., 125, 87-99.
17. McPherson JD, Marra M, Hillier L, Waterston RH, Chinwalla A, Wallis J, Sekhon M, Wylie K, Mardis ER, Wilson RK, Fulton R, Kucaba TA, Wagner-McPherson C, Barbazuk WB, Gregory SG, Humphray SJ, French L, Evans RS, Bethel G, Whittaker A, Holden JL, McCann OT, Dunham A, Soderlund C, Scott CE, Bentley DR, Schuler G, Chen HC, Jang W, Green ED, Idol JR, Maduro VV, Montgomery KT, Lee E, Miller A, Emerling S, Kucherlapati RS, Gibbs R, Scherer S, Gorrell JH, Sodergren E, Clerc-Blankenburg K, Tabor P, Naylor S, Garcia D, de Jong PJ, Catanese JJ, Nowak N, Osoegawa K, Qin S, Rowen L, Madan A, Dors M, Hood L, Trask B, Friedman C, Massa H, Cheung VG, Kirsch IR, Reid T, Yonescu R, Weissenbach J, Bruis T, Heilig R, Branscomb E, Olsen A, Doggett N, Cheng JF, Hawkins T, Myers RM, Shang J, Ramirez L, Schmutz J, Velasquez O, Dixon K, Stone NE, Cox DR, Haussler D, Kent WJ, Furey T, Rogic S, Kennedy S, Jones S, Rosenthal A, Wen G, Schilhabel M, Gloeckner G, Nyakatura G, Siebert R, Schlegelberger B, Korenberg J, Chen XN, Fujiyama A, Hattori M, Toyoda A, Yada T, Park HS, Sakaki Y, Shimizu N, Asakawa S, Kawasaki K, Sasaki T, Shintani A, Shimizu A, Shibuya K, Kudoh J, Minoshima S, Ramser J, Seranski P, Hoff C, Poustka A, Reinhardt R and Lehrach H. (2001). Nature, 409, 934-941.
18. McWilliams A, MacAulay C, Gazdar AF and Lam S. (2002). Oncogene, 21, 6949-6959.
19. Minna JD, Roth JA and Gazdar AF. (2002). Cancer Cell, 1, 49-52.
20. Osada H and Takahashi T. (2002). Oncogene, 21, 7421-7434.
21. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrock E, du Manoir S and Cremer T. (1994). Cancer Res., 54, 1801-1806.
22. Saretzki G, Petersen S, Petersen I, Kolble K and von Zglinicki T. (2002). Cancer Lett., 176, 81-91.
23. Siwoski A, Ishkanian A, Garnis C, Zhang L, Rosin M and Lam WL. (2002). Mod Pathol., 15, 889-892.
24. Takahashi M. (2001). Cytokine Growth Factor Rev., 12, 361-373.
25. Travis WD, Colby TV, Corrin B, Shimosato Y and Brambilla E. (1999). Histological Typing of Lung and Pleural Tumours with Contributions by Pathologists from 14 Countries, 3rd edn. Springer Verlag: Berlin.
26. Ullmann R, Schwendel A, Klemen H, Wolf G, Petersen I and Popper HH. (1998). Hum. Pathol., 29, 1145-1149.
27. Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR, Shepherd FA, Minden MD and Tsao MS. (2002). Oncogene, 21, 7598-7604.
28. Watson SK, deLeeuw RJ, Ishkanian AS, Malloff CA and Lam WL. (2004). BMC Genomics, 5, 6.
29. Wiebe JP and Lewis MJ. (2003). BMC Cancer, 3, 9.
30. Wieland I and Bohm M. (1994). Cancer Res., 54, 1772-1774.
31. Wieland I, Bohm M, Arden KC, Ammermuller T, Bogatz S, Viars CS and Rajewsky MF. (1996). Oncogene, 12, 97-102.
32. Wistuba II, Berry J, Behrens C, Maitra A, Shivapurkar N, Milchgrub S, Mackay B, Minna JD and Gazdar AF. (2000). Clin. Cancer Res., 6, 2604-2610.
33. Zabarovsky ER, Lerman MI and Minna JD. (2002). Oncogene., 21, 6915-6935.
34. Zheng M, Simon R, Mirlacher M, Maurer R, Gasser T, Forster T, Diener PA, Mihatsch MJ, Sauter G and Schraml P. (2004). Am. J. Pathol., 165, 63-69.
35. Zhu CQ, Blackhall FH, Pintilie M, Iyengar P, Liu N, Ho J, Chomiak T, Lau D, Winton T, Shepherd FA and Tsao MS. (2004). Clin. Cancer Res., 10, 1984-1991.